Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
Clinical trial NCT02715284 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02715284
- Sponsor
- Tesaro, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-07
- Primary completion
- 2026-05-18
- Enrollment
- 730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.